NHSA Mandates National Standards for Medical Consumables in Basic Medical Insurance
The National Healthcare Security Administration (NHSA) has released a notification with a focus on enhancing...
NHSA (prev. SMIA)
China Releases Third List of Pediatric Drugs to Guide Development and Filings
The National Health Commission (NHC), National Healthcare Security Administration, National Medical Products Administration (NMPA), and...
NHSA Releases Preliminary Review Results for National Reimbursement Drug List Adjustments
The National Healthcare Security Administration (NHSA) has released a notification disclosing the drugs that have...
National Health Commission’s Anti-Corruption Drive Impacts China’s Pharmaceutical Sector
An anti-corruption crackdown announced by the National Health Commission (NHC) at the end of July...
NHSA Issues 2023 Guidelines: Enhancing Basic Medical Insurance and Major Illness Coverage
The National Healthcare Security Administration (NHSA) has released the “Notice on Ensuring Basic Healthcare Security...
NHSA Releases Official Guidelines for Drug Negotiations and Bidding for NRDL Update
The National Healthcare Security Administration (NHSA) has officially released the “Negotiation Drug Renewals” and “Non-exclusive...
National Health Commission Launches One-Year Anti-Corruption Campaign in Pharmaceutical Sector
The emergency response department of the National Health Commission (NHC) has released a notification signaling...
NHSA Unveils 2023 Flying Inspection Plan for Medical Insurance Fund Oversigh
The National Healthcare Security Administration (NHSA) has released its 2023 Basic Medical Insurance (BMI) Fund...
NHSA’s 2022 Report: BMI Fund Income Rises 7.6%, Outgoing Expenditure Increases 2.3%
The National Healthcare Security Administration (NHSA) has released its annual statistical report for 2022, detailing...
NHSA Unveils Updated National Reimbursement Drug List Rules for 2023
The National Healthcare Security Administration (NHSA) has released the updated rules that will govern this...
NHSA Unveils 2023 Work Plan for National Reimbursement Drug List Update
The National Healthcare Security Administration (NHSA) has released the “Work Plan for the National Reimbursement...
NHSA Report Highlights ‘Flying Inspections’ Impact on Medical Insurance Fund Use in 2022
The National Healthcare Security Administration (NHSA) has released a report outlining the outcomes of ‘flying...
NHSA Launches 2023 NRDL Update Process with New Work Plan and Public Feedback Period
The National Healthcare Security Administration (NHSA) has commenced the process for the annual update of...
Eccogene Secures $25 Million in Series B Financing to Advance Metabolic Disease Therapies
Sino-US firm Eccogene Inc. has announced the closure of a Series B financing round, raising...
Hainan Province and NHSA Partner to Enhance Medical Insurance Industry with Real-World Data
The government of Hainan province has entered into a strategic partnership with the National Healthcare...
NHSA Proposes Draft to Enhance Basic Medical Insurance Payment Management for Consumables
The National Healthcare Security Administration (NHSA) has issued a Notice seeking public feedback on draft...
China’s NHC and 13 Bureaus Launch Campaign to Rectify Pharmaceutical and Medical Services Practices
The National Health Commission (NHC) along with 13 other bureaus has jointly released a notification...
Chinese Authorities Launch Special Campaign to Combat Fraud in Medical Insurance
The National Healthcare Security Administration, Supreme People’s Procurator, Ministry of Public Security, Ministry of Finance,...
China’s NHSA Introduces Tiered Pricing for COVID-19 Therapies: A, B, and C Categories
The National Healthcare Security Administration (NHSA) has issued a Notification concerning the improvement of the...
NHSA Launches Crackdown on Medical Insurance Fund Management with New Inspection Measures
The National Healthcare Security Administration (NHSA) is intensifying efforts to manage medical insurance funds at...